TrumpRx Didn’t Lower Drug Prices. That’s the Point.

Yesterday morning my phone started blowing up…

A bunch of my MAGA-supporting friends were texting me screenshots from the White House press conference announcing the expansion of TrumpRx. Trump standing next to Mark Cuban, RFK, and Dr. Oz. Big smiles. American flags. Headlines about “600 generic drugs” being added to the platform.

Those friends have not been happy with my past reluctance to give Trump effusive praise for his impact on the world of pharmacy. And to them, as well as many Americans, yesterday appeared to be a monumental victory for that campaign. I honestly couldn’t blame them for buying into it knowing that they hadn’t thought too critically about what it actually meant.

If you only saw the imagery, it certainly looked like a groundbreaking healthcare achievement. The White House framed it that way.

But once I looked into what actually changed, I confirmed what I already knew:

TrumpRx didn’t lower the price of a single generic drug in America.

Not one.

What this deal accomplished is much simpler than that.

The government essentially turned TrumpRx into a search engine for cash prices on generic medications that were already available through companies like Mark Cuban’s Cost Plus Drugs, Amazon Pharmacy, and GoodRx.

That’s the deal.

The prices were already there.

TrumpRx just aggregated them into one place.

And strangely enough… I still think that’s important.

Because if the most useful healthcare innovation of 2026 is simply a website showing Americans the cash price of generic drugs… that says something deeply troubling about the system we built.

What TrumpRx Actually Is

The original version of TrumpRx mostly focused on branded drugs and “Presidential Deals” negotiated directly with pharmaceutical companies.

I already wrote about why I found a lot of that political theater. Many of the drugs highlighted were niche specialty medications that very few Americans were realistically paying cash for anyway.

Yesterday’s announcement added a component to the site that is very different.

Now, alongside those “Presidential Deals,” the site includes a giant list of generic medications that redirect patients toward existing cash pricing through:

  • Cost Plus Drugs

  • Amazon Pharmacy

  • GoodRx coupon pricing

That is genuinely useful.

But let’s be very clear about something:

TrumpRx did not negotiate lower generic drug prices.

It did not force manufacturers to cut prices.
It did not reform PBMs.
It did not change pharmacy reimbursement.
It did not alter insurance design.
It did not fix rebates.
It did not eliminate spread pricing.

It mostly embedded APIs from existing pricing tools into a government-branded website.

That’s not a revolution.
It’s aggregation.

To borrow a line from healthcare consultant Brian Reid that made me laugh out loud:

“Taking credit for low generic drug prices is like taking credit for the sun rising.”

The Part Most Americans Don’t Understand

Here’s the reality most consumers never see:

Many generic drugs are already absurdly cheap.

Not “cheaper than brand-name drugs.”
I mean genuinely cheap.

I want to show you an example from Cost Plus Drugs because I think it perfectly illustrates the entire story.

This is a real pricing breakdown for a 30-day supply of Montelukast (brand name: Singulair), a common asthma medication:

  • Manufacturing Cost: $0.69

  • 15% Markup: $0.10

  • Pharmacy Labor: $5.00

  • Shipping: $5.25

Total: $5.79 before shipping.

Read that again.

The actual medication costs sixty-nine cents after a 15% markup.

Not $69.
Not $16.
Not even $5.

Sixty-nine cents.

The drug itself costs less than a bottle of Poland Spring.

And honestly, that screenshot explains more about modern healthcare than most congressional hearings do.

For decades, Americans have been conditioned to believe that “prescription drugs are expensive.”

Sometimes they are. Especially brand-name and specialty medications.

But for many generics, that’s no longer really the case.

What’s expensive is:

  • the insurance architecture

  • the PBM ecosystem

  • administrative complexity

  • hidden rebates

  • opaque pricing

  • and the complete lack of transparency around what things actually cost

The molecule itself? Often dirt cheap.

Insurance Has Become Weird

This is where the story gets deeply, uniquely American.

One of the strangest parts of the modern pharmacy system is that insurance is increasingly not the best way to buy many generic medications.

Think about how insane that sentence is.

You pay monthly premiums.
Your employer pays monthly premiums.
Your entire healthcare plan is built around the idea of insurance coverage.

And yet, in many cases, the cheapest way to buy medication is to pretend your insurance doesn’t exist.

That’s not how healthcare is supposed to function.

Sometimes patients walk into my pharmacy and their insurance copay for a generic medication is higher than the cash price.

Sometimes dramatically higher.

Why?

Because the insurance system isn’t really optimized around transparency or simplicity anymore. It’s optimized around contracts, networks, formularies, rebates, fees, and incentives layered on top of each other over decades.

The result is a pricing structure so distorted that consumers often have no idea whether their medication actually costs:

  • $5

  • $50

  • or $500

until the claim adjudicates at the register.

That’s insane.

And the craziest part?

PBMs are often perfectly happy about it.

Why PBMs Don’t Hate This

At first glance, you might assume PBMs would hate TrumpRx encouraging patients to bypass insurance.

Not necessarily.

For cheap generics, PBMs frequently don’t care if patients go outside the benefit structure because:

  • generic drugs have minimal rebate value

  • paying claims costs money

  • and bypassing insurance means patients don’t accumulate deductible spending

That last point is the most important.

If a patient buys a medication through TrumpRx, Cost Plus, Amazon, or GoodRx cash pricing, nine times out of ten that purchase does not count toward:

  • deductibles

  • out-of-pocket maximums

  • or insurance benefit accumulation

In other words: patients are still paying insurance premiums while increasingly being nudged towards not using the insurance they’re paying for.

That’s the upside-down reality we now live in.

The PBMs avoid paying the claim.
The insurer avoids spending money.
The patient gets a lower immediate price…
…but steps outside the benefit structure they already purchased.

American healthcare has become so distorted that the system now celebrates you NOT using the benefits you’re paying monthly premiums for.

You almost have to admire how absurdly efficient the scam has become.

The Future I Think We’re Heading Towards

The more I think about all of this, the more I believe we are drifting toward a healthcare system split into two separate worlds.

One world will be catastrophic insurance:

  • surgeries

  • hospitalizations

  • cancer treatment

  • biologics

  • emergencies

The other will increasingly become a transparent cash-pay marketplace for routine medications.

And honestly? For many generic drugs, that may actually be more rational than the system we have now.

If the actual medication costs under a dollar to manufacture, it doesn’t need:

  • rebate structures

  • PBM intermediaries

  • prior authorizations

  • spread pricing

  • opaque reimbursements

  • and twelve layers of administrative nonsense

In that kind of future, a transparent search engine comparing drug prices across pharmacies and suppliers actually becomes extremely valuable.

Which is why, despite all my skepticism about the political branding and spectacle surrounding TrumpRx, I still have to admit something:

This is probably a net positive.

Because even though it didn’t lower drug pricing, millions of Americans are suddenly learning these alternative options exist.

And awareness is my number one mission here at Drugstore Cowboy HQ.

Healthcare in this country survives on confusion.
Confusion is the system’s greatest defense mechanism.

The moment consumers start to understand how the system works and their options for opting out of it, that is when we start to make progress.

The Real Takeaway

The funniest part of this entire story is that the actual technology involved here is incredibly basic.

It’s basically a glorified price-comparison website.

And yet it feels revolutionary because American healthcare pricing has become so opaque that simple visibility now feels disruptive.

That should make us all embarrassed.

For all the branding and political theater surrounding TrumpRx, the most valuable thing it may ultimately do is teach Americans a simple truth:

Many generic drugs were already cheap and easy to get. Most people just never comparison-shop prescriptions because the healthcare system trained them not to.

And, I’ll say it again, if the most useful healthcare innovation of 2026 is simply a website showing Americans the cash price of generic drugs… that says something deeply troubling about the system we built.

How beautiful that the same people who are patting themselves on the back for creating it are the only ones who have the power to fix it.

God Bless America!

Alec Wade Ginsberg, PharmD, RPh
4th-Gen Pharmacist | Owner & COO, C.O. Bigelow
Founder, Drugstore Cowboy

Keep Reading